Dr. Rabia Z. Bhatti with the AMITA Resurrection Medical Center has always had a strong interest in the art of surgery. “I actually love the way that patients recover,” she explained. “There’s a gratification behind treating patients and watching them get better. And after practicing general surgery for 15 years, I realized I could provide even better care to my patients by focusing, and staying ahead, on one specialty. That’s when I made the switch to breast surgery.”
“From now on, I’m going to use MarginProbe on all of my lumpectomy cases,” the Coordinated Health surgeon shared. “Somehow we have been losing control of how to use new technology to better the lives of patients and their care. That has been our battle and I think it is becoming more pronounced."
"One of the fun things about my job is that NO day is typical," Lisa explained. "I can start the day reviewing pathology reports and analyzing MarginProbe’s contribution to a surgeon’s outcomes in preparation for a data review, and then end the day by updating a training deck for our new hire training class. My position is never boring, and I get to have my fingers in everything!"
With 30 years in practice, Dr. Daniel Howard, a General Surgeon at Mercy Health — Lourdes Hospital, can still define exactly what attracted him to surgery. Dr. Howard’s practice at Mercy Health is the only facility in the state of Kentucky to take advantage of MarginProbe, and it’s leading the state, and the nation, in many other areas of breast cancer treatment.
Every breast cancer survivor has a unique story to tell, and Alexa G is no exception. Her experience highlights the importance of patients becoming their own strongest advocate.
The Johns Hopkins Breast Center at Johns Hopkins Hospital, the #3 hospital in the U.S. News & World Report’s 2018–19 Best Hospitals list, announced that it will be adding MarginProbe® as a regular part of its program after its participation in Dune Medical’s MarginProbe® Post Approval Study (PAS).
Dune Medical Devices has reached another milestone in their MarginProbe® Post Approval Study (PAS) as Johns Hopkins Hospital and Moffitt Cancer Center complete their patient enrollments for the trial.
Dune Medical Devices was thrilled to host Congresswoman Lucy McBath in a recent visit to their Alpharetta office. McBath is a member of the United States House of Representatives from Georgia's 6th congressional district. Since joining Congress in January of this year, she has shown support for multiple bills seeking to lower costs of healthcare for patients and help advance medical innovation.
As part of their whole-person care strategy, Dr. Wilson’s practice uses a new tool, known as MarginProbe, to ensure that a safe margin of tissue is removed around a cancerous tumor as that tumor is removed during surgery.
Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radio-frequency (RF) spectroscopy technology.
Sun27Oct2019Thu31Oct2019San Francisco, CA
American College of Surgeons Clinical Congress